Law, History and Lessons in the CRISPR Patent Conflict
Nature Biotechnology, Vol. 33, pp. 256-57, March 2015
2 Pages Posted: 17 Mar 2015
Date Written: March 13, 2015
Predicting the outcome of the ongoing patent disputes surrounding genome-editing technology is equal parts patent analysis and history.
Genome-editing technology based on clustered, regularly interspaced, short palindromic repeats (CRISPR) and CRISPR associated protein 9 (Cas9) has generated great excitement in both academia and industry. But a potential patent dispute between two sets of inventors has left the biotech community pondering its fate. Understanding several facets of patent law and history may provide some lessons about the probable — and best — outcome for the dispute.
Keywords: intellectual property, patent, biotech, biotechnology, crispr, genetics
JEL Classification: K00, K23, K41, O3, O34, D23, K11
Suggested Citation: Suggested Citation